Stock comparison
ELI LILLY & Co is 579.5x more valuable than Lakefront Biotherapeutics NV by market capitalization ($1.282 T vs $2.21 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 579.5x more valuable than Lakefront Biotherapeutics NV by market capitalization ($1.282 T vs $2.21 B).
Market value leader
LLY
ELI LILLY & Co is 579.5x more valuable than Lakefront Biotherapeutics NV by market capitalization ($1.282 T vs $2.21 B).
| Metric | LKFT | LLY |
|---|---|---|
| Market cap | $2.21 B | $1.282 T |
| US-listed rank | #2011 | #10 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | - | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 62.1x |
| SEC filings | 505 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 579.5x more valuable than Lakefront Biotherapeutics NV by market capitalization ($1.282 T vs $2.21 B).
Full pages: Lakefront Biotherapeutics NV and ELI LILLY & Co, or browse the full rankings.